Intervention
Magnesium
Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
RCT evidence— Multiple BP meta-analyses; sleep + migraine smaller trials
Why it matters
- Cofactor for 300+ enzymes including ATP synthesis, DNA repair, glucose metabolism.
- Population-level deficiency: ~50% of US adults below RDA.
- Serum magnesium is a poor reflection of total-body status; RBC magnesium or ionised magnesium are better but not routine.
Forms (matters for absorption and effect)
| Form | Bioavailability | Best for |
|---|---|---|
| Glycinate / bisglycinate | High | Sleep, anxiety, general |
| Citrate | High | Constipation, general |
| L-threonate | High | Cognitive (crosses BBB) |
| Malate | High | Fatigue, fibromyalgia |
| Chloride | High | Topical / spray |
| Oxide | Very low | Avoid (used in cheap supplements) |
| Sulphate | Low oral | IV use; Epsom-salt baths |
Evidence-based uses
- Blood pressure: meta-analysis shows ~2/1.8 mmHg reduction with ~300 mg/day; larger in baseline-deficient.
- Sleep onset: small benefit, particularly glycinate.
- Migraine prevention: ~400–600 mg/day reduces frequency in meta-analyses.
- Type-2 diabetes: improves insulin sensitivity in deficient adults.
- Constipation: citrate effective laxative.
Cautions
- Renal impairment: risk of hypermagnesaemia.
- PPI users: long-term PPI use can cause magnesium deficiency.
- High doses can interfere with absorption of some antibiotics, levothyroxine.
Related entries
References
- Zhang, X. et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension 68, 324–333 (2016).